Concept:
The primary histology for anal cancer is Squamous Cell Carcinoma (SCC). The management paradigm for anal SCC is distinct from rectal adenocarcinoma and prioritizes organ preservation.
Explanation:
• Historically, anal cancer was treated surgically with an Abdominoperineal Resection (APR), which leaves the patient with a permanent colostomy.
• The introduction of the Nigro Protocol revolutionized the management of this disease. Anal SCC is highly radiosensitive and chemosensitive.
• The current gold standard primary treatment for non-metastatic anal squamous cell carcinoma is definitive Chemoradiotherapy (Option A). This typically involves external beam radiation combined with concurrent chemotherapy (usually 5-Fluorouracil and Mitomycin C).
• This approach achieves excellent local control and high cure rates while preserving the anal sphincter mechanism in the vast majority of patients.
• Radical surgery, specifically Abdominoperineal Resection (APR, Option B), is strictly reserved for "salvage" therapy—meaning it is only used for patients who fail to respond to chemoradiotherapy or who suffer a local recurrence later.
Final Answer:
Anal cancer without distant metastasis is primarily treated with definitive chemoradiotherapy (the Nigro protocol) to achieve cure with sphincter preservation.